239 related articles for article (PubMed ID: 7980801)
1. Practical Bayesian guidelines for phase IIB clinical trials.
Thall PF; Simon R
Biometrics; 1994 Jun; 50(2):337-49. PubMed ID: 7980801
[TBL] [Abstract][Full Text] [Related]
2. Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design.
Taylor JM; Braun TM; Li Z
Clin Trials; 2006; 3(4):335-48. PubMed ID: 17060208
[TBL] [Abstract][Full Text] [Related]
3. Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: a tutorial.
Zohar S; Teramukai S; Zhou Y
Contemp Clin Trials; 2008 Jul; 29(4):608-16. PubMed ID: 18201945
[TBL] [Abstract][Full Text] [Related]
4. Bayesian sample size calculations in phase II clinical trials using informative conjugate priors.
Mayo MS; Gajewski BJ
Control Clin Trials; 2004 Apr; 25(2):157-67. PubMed ID: 15020034
[TBL] [Abstract][Full Text] [Related]
5. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
Johnson VE; Cook JD
Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian predictive two-stage design for phase II clinical trials.
Sambucini V
Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
[TBL] [Abstract][Full Text] [Related]
7. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
8. A Bayesian predictive strategy for an adaptive two-stage design in phase II clinical trials.
Sambucini V
Stat Med; 2010 Jun; 29(13):1430-42. PubMed ID: 20099246
[TBL] [Abstract][Full Text] [Related]
9. Continuous toxicity monitoring in phase II trials in oncology.
Ivanova A; Qaqish BF; Schell MJ
Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
[TBL] [Abstract][Full Text] [Related]
10. A parallel phase I/II clinical trial design for combination therapies.
Huang X; Biswas S; Oki Y; Issa JP; Berry DA
Biometrics; 2007 Jun; 63(2):429-36. PubMed ID: 17688495
[TBL] [Abstract][Full Text] [Related]
11. Bayesian decision sequential analysis with survival endpoint in phase II clinical trials.
Zhao L; Woodworth G
Stat Med; 2009 Apr; 28(9):1339-52. PubMed ID: 19226557
[TBL] [Abstract][Full Text] [Related]
12. A standardization method to adjust for the effect of patient selection in phase II clinical trials.
Mazumdar M; Fazzari M; Panageas KS
Stat Med; 2001 Mar; 20(6):883-92. PubMed ID: 11252010
[TBL] [Abstract][Full Text] [Related]
13. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II designs in cancer clinical trials: current status and future directions.
Lee JJ; Feng L
J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility probability in clinical trials.
Shao J; Chow SC
Stat Med; 2002 Jun; 21(12):1727-42. PubMed ID: 12111908
[TBL] [Abstract][Full Text] [Related]
16. Early selection in a randomized phase II clinical trial.
Steinberg SM; Venzon DJ
Stat Med; 2002 Jun; 21(12):1711-26. PubMed ID: 12111907
[TBL] [Abstract][Full Text] [Related]
17. Release of data from an ongoing randomized clinical trial for sample size adjustment or planning.
Freidlin B; Korn EL
Stat Med; 2007 Sep; 26(22):4074-82. PubMed ID: 17328095
[TBL] [Abstract][Full Text] [Related]
18. Continuous Bayesian adaptive randomization based on event times with covariates.
Cheung YK; Inoue LY; Wathen JK; Thall PF
Stat Med; 2006 Jan; 25(1):55-70. PubMed ID: 16025549
[TBL] [Abstract][Full Text] [Related]
19. Sample size tables for exact single-stage phase II designs.
A'Hern RP
Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008
[TBL] [Abstract][Full Text] [Related]
20. Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.
Schmidli H; Bretz F; Racine-Poon A
Stat Med; 2007 Nov; 26(27):4925-38. PubMed ID: 17590875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]